- Neogen Corporation has appointed Jennifer Evans Stacey as chief legal and compliance officer and board secretary.
- Stacey brings more than 25 years of experience in legal, compliance, and governance roles within the life sciences industry.
- She previously served as chief legal and compliance officer at Galera Therapeutics.
- Stacey has also held leadership positions at The Wistar Institute, Antares Pharma, FXI, Auxilium Pharmaceuticals, and Aventis Behring.
- The appointment supports Neogen’s focus on growth through innovation, technology licensing, and strategic expansion.
Neogen Corporation announced the appointment of Jennifer Evans Stacey as chief legal and compliance officer and board secretary.
Stacey brings more than 25 years of experience leading legal, compliance, governance, and corporate affairs functions in the life sciences sector. Her background includes more than a decade serving as a chief legal and compliance officer for publicly traded companies as well as experience as a public company board member.
Leadership Experience in Life Sciences
Most recently, Stacey served as chief legal and compliance officer and secretary at Galera Therapeutics, a publicly traded biopharmaceutical company focused on oncology therapies.
Earlier in her career, she held chief legal officer positions at several organizations including The Wistar Institute, Antares Pharma, FXI, Auxilium Pharmaceuticals, and Aventis Behring.
She currently serves on the board of directors of Context Therapeutics, a clinical-stage biopharmaceutical company developing T cell-engaging bispecific antibodies for solid tumors.
Supporting Governance and Strategic Growth
Neogen leadership said Stacey’s appointment supports the company’s focus on strengthening governance and supporting long-term growth initiatives.
The company develops solutions across food safety, livestock, and pet health markets, with operations spanning more than 140 countries.
Information sourced from the company’s press release.
